Yahoo Web Search

  1. Bayer Gets Temporary Relief from Its Monsanto-Roundup Woes

    Fortune via Yahoo FinanceApr 25 9:16 AM

    Bayer AG’s earnings report gave Chief Executive Officer Werner Baumann a welcome boost as he prepares for a key meeting Friday where some investors will vent concerns about the ...

  2. Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon

    Zacks via Yahoo FinanceApr 11 22:20 PM

    Novartis AG’s NVS) generic arm, Sandoz, signed an agreement with Japanese pharmaceutical company, Shionogi & Co Ltd, for commercialization of Rizmoic in the key European markets of Germany ...

  3. Bayer Gets Boost From Agriculture as Investor Meeting Looms

    Bloomberg via Yahoo FinanceApr 25 8:55 AM

    Bayer rose as much as 4.5 percent in Frankfurt, its biggest gain since early January. Monsanto’s growth rate is welcome news for Baumann, coming despite flooding in the U.S. Midwest that ...

  4. Based on FDA’s feedback, Ra Pharma plans to initiate a pivotal, phase III study to evaluate the efficacy of a once-daily, subcutaneously (SC) self-administered dose of 0.3 mg/kg of zilucoplan ...

  5. Shares of AVEO Pharmaceuticals, Inc. AVEO have witnessed a sharp decline in the past three months, underperforming its industry. Notably, this January, AVEO faced a major setback when it had ...

  6. 2 Best Biotech Buyout Plays

    Motley Fool via Yahoo FinanceApr 23 12:44 PM

    For example, early-bird investors who bought shares of Avexis, Clementia, Kite Pharma, Juno Therapeutics, Nightstar Therapeutics, and Spark Therapeutics all walked away with enormous ...

  7. Let's move on to take the Technical & Pharma. The business grew 5% organically in the first quarter compared with the same quarter last year. This was slightly better than expected but ...

  1. Ad
    related to Bayer Pharma AG